Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180787 · ClinicalTrials.gov registry record · NA
Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance
A NA study of Metabolism and Exercise Performance, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT04180787: Completed NA study of Metabolism and Exercise Performance, sponsored by Texas Tech University.
NCT04180787 is a NA study of Metabolism and Exercise Performance that has completed, run by Texas Tech University. The registered enrollment target is 19 participants, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04180787, a NA study of Metabolism and Exercise Performance, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized, double-blind, crossover study is to investigate the effects of Bang® Keto Coffee on resting and post-exercise metabolism and muscular performance during lower body resistance exercise.
Primary Outcome
Isometric force production on mechanized squat device
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Beverage Consumption
Study Locations (1)
Texas
- Department of Kinesiology & Sport Management - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-12-05 |
| Est. Completion | 2020-03-09 |
| Phase | NA |
What the finished NCT04180787 record still lists
NCT04180787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Metabolism appearing as the primary indexed condition, and to 1 intervention - of which Beverage Consumption is the first listed.
NCT04180787 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04180787 about?
NCT04180787 is a clinical study titled "Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance". The purpose of this randomized, double-blind, crossover study is to investigate the effects of Bang® Keto Coffee on resting and post-exercise metabolism and muscular performance during lower body resistance exercise.
What is the current status of trial NCT04180787?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-12-05. Estimated completion is 2020-03-09.
What conditions does trial NCT04180787 study?
This clinical trial studies the following conditions: Metabolism, Exercise Performance.
What interventions are being tested in trial NCT04180787?
The interventions under investigation include: Beverage Consumption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04180787?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04180787 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04180787's enrollment target sits among peer trials
19 13th of 19 higher than 7 of 19 other Metabolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
ACTIVE NOT RECRUITING · NA
-
Duration of Physical Inactivity and Postprandial Lipid Metabolism
COMPLETED · NA
-
Metabolic Effects of a Thermogenic Ready-to-drink Beverage
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI